オノ マサフミ   Ono Masafumi
  小野 正文
   所属   医学部 医学科(附属足立医療センター)
   職種   非常勤講師
論文種別 原著
言語種別 英語
査読の有無 査読あり
表題 Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients.
掲載誌名 正式名:Hepatology research : the official journal of the Japan Society of Hepatology
略  称:Hepatol Res
ISSNコード:1872034X/13866346
掲載区分国内
巻・号・頁 42(11),pp.1058-64
著者・共著者 Koda Masahiko, Murawaki Yoshikazu, Hirooka Yasuaki, Kitamoto Mikiya, Ono Masafumi, Sakaeda Hiroshi, Joko Kouji, Sato Shuichi, Tamaki Katsuyoshi, Yamasaki Takahiro, Shibata Hiroshi, Shimoe Toshinari, Matsuda Tadakazu, Toshikuni Nobuyuki, Fujioka Shin-Ichi, Ohmoto Kenji, Nakamura Shinichiro, Kariyama Kazuya, Aikata Hiroshi, Kobayashi Yoshiyuki, Tsutsui Akemi
発行年月 2012/11
概要 AIM:  We surveyed multiple centers to identify types and frequency of complications and mortality rate associated with radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC).METHODS:  We distributed a questionnaire developed by members of the Chugoku-Shikoku Society for the Local Ablation Therapy of Hepatocellular Carcinoma to 20 centers and analyzed types and frequency of complications and mortality rate.RESULTS:  In total, 16 346 nodules were treated in 13 283 patients between January 1999 and November 2010. Five patients (0.038%) died: two from intraperitoneal hemorrhage, and one each from hemothorax, severe acute pancreatitis and perforation of the colon. In 16 346 treated nodules, 579 complications (3.54%) were observed, including 78 hemorrhages (0.477%), 276 hepatic injuries (1.69%), 113 extrahepatic organ injuries (0.691%) and 27 tumor progressions (0.17%). The centers that treated a large number of nodules and performed RFA modifications, such as use of artificial ascites, artificial pleural effusion and bile duct cooling, had low complication rates.CONCLUSION:  This study confirmed that RFA is a low-risk treatment for HCC and that sufficient experience and technical skill can reduce complications.
DOI 10.1111/j.1872-034X.2012.01025.x
PMID 22583706